Summary
-
1.
The effects of erythro-1-{1-[2-(1,4-benzodioxan-2-yl)-2-hydroxyethyl]-4-piperidyl}-2-benzimidazolinone (R 28935), prazosin and phenoxybenzamine on the clonidine-induced increases in the flexor relfex activity and in the blood pressure of rats were used to study their influence on postsynaptic α-adreno-receptors centrally and peripherally, respectively. R 28935 was more potent in blocking the central than the peripheral α-adrenoreceptors whereas the two receptor types were inhibited to about the same degree following prazosin and phenoxybenzamine.
-
2.
The amphetamine-induced rotation of rats with unilateral inactivation of the corpus striatum and the apomorphine-induced stimulation of the motor activity of mice were inhibited by R 28935, but not by prazosin, indicating that R 28935 can block postsynaptic dopaminergic receptors.
-
3.
The α-methyltyrosine-induced disappearance of noradrenaline in the brain and the spinal cord of rats was only slightly accelerated by prazosin but was more effectively accelerated by R 28935 and phenoxybenzamine. The deceleration by clonidine of the α-methyltyrosine-induced disappearance of noradrenaline was partially inhibited by R 28935 but was not influenced by prazosin indicating that central α-autoreceptors (presynaptic α-receptors) are only weakly blocked by R 28935 and not at all blocked by prazosin.
-
4.
The blood pressure of intact rats was lowered by prazosin and phenoxybenzamine at doses effectively blocking vascular α-adrenoreceptors. On the other hand, R 28935 caused hypotension at doses blocking central but not peripheral α-adrenoreceptors suggesting that the hypotension might be due to inhibition of central noradrenergic neurotransmission.
Similar content being viewed by others
References
Andén, N.-E., Grabowska, M.: Pharmacological evidence for a stimulation of dopamine neurons by noradrenaline neurons in the brain. Eur. J. Pharmacol. 39, 275–282 (1976)
Andén, N.-E., Grabowska, M., Strömbom, U.: Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents. Naunyn-Schmiedeberg's Arch. Pharmacol. 292, 43–52 (1976)
Andén, N.-E., Strömbom, U., Svensson, T. H.: Dopamine and noradrenaline receptor stimulation: reversal of reserpine-induced suppression of motor activity. Psychopharmacologia (Berl.) 29, 289–298 (1973)
Andén, N.-E., Corrodi, H., Dahlström, A., Fuxe, K., Hökfelt, T.: Effects of tyrosine hydroxylase inhibition on the amine levels of central monoamine neurons. Life Sci. 5, 561–568 (1966)
Andén, N.-E., Corrodi, H., Fuxe, K., Hökfelt, B., Hökfelt, T., Rydin, C., Svensson, T.: Evidence for a central noradrenaline receptor stimulation by clonidine. Life Sci. 9, (I), 513–523 (1970)
Andén, N.-E., Gomes, C., Grabowska, M., Persson, B., Trolin, G.: Effects of some antihypertensive agents on α-adrenoreceptor activity centrally and peripherally. Acta pharmacol. (Kbh.) 41, Suppl. IV, 19 (1977)
Andén, N.-E., Rubenson, A., Fuxe, K., Hökfelt, T.: Evidence for dopamine receptor stimulation by apomorphine. J. Pharm. Pharmacol. 19, 627–629 (1967)
Atack, C. V.: The determination of dopamine by a modification of the dihydroxyindole fluorimetric assay. Br. J. Pharmacol. 48, 699–714 (1973)
Atack, C. V., Magnusson, T.: Individual elution of noradrenaline (together with adrenaline), dopamine, 5-hydroxytryptamine and histamine from a single, strong cation exchange column, by means of mineral acid-organic solvent mixtures. J. Pharm. Pharmacol. 22, 625–627 (1970)
Bertler, Å., Carlsson, A., Rosengren, E.: A method for the fluorimetric determination of adrenaline and noradrenaline in tissues. Acta Physiol. Scand. 44, 273–292 (1958)
Cambridge, D., Davey, M. J., Massingham, R.: Prazosin, a selective antagonist of post-synaptic α-adrenoceptors. Br. J. Pharmacol. 59, 514P-515P (1977)
Constantine, J. W., McShane, W. K., Scriabine, A., Hess, H.-J.: Analysis of the hypotensive action of prazosin. In: Hypertension: mechanisms and management (G. Onesti, K. E. Kim, and J. H. Moyer, eds.), pp. 429–444. New York: Grunne & Stratton 1973
Corrodi, H., Hanson, L. C. F.: Central effects of an inhibitor of tyrosine hydroxylation. Psychopharmacologia (Berl.) 10, 116–125 (1966)
Doxey, J. C., Smith, C. F. C., Walker, J. M.: Selectivity of blocking agents for pre-and postsynaptic α-adrenoceptors. Br. J. Pharmacol. 60, 91–96 (1977)
Engström, G., Svensson, T. H., Waldeck, B.: Thyroxine and brain catecholamines: increased transmitter synthesis and increased receptor sensitivity. Brain Res. 77, 471–483 (1974)
Finch, L.: A centrally acting antihypertensive agent (R 28935) not mediated via central α-adrenoreceptors. Eur. J. Pharamcol. 33, 409–412 (1975)
Graham, R. M., Oates, H. F., Stoker, L. M., Stokes, G. S.: Alpha blocking action of the antihypertensive agent, prazosin, J. Pharmacol. Exp. Ther. 201, 747–752 (1977)
Häggendal, J.: An improved method for fluorimetric determination of small amounts of adrenaline and noradrenaline in plasma and tissues. Acta Physiol. Scand. 59, 242–254 (1963)
Heise, A., Kroneberg, G.: Central nervous α-adrenergic receptors and the mode of action of α-methyldopa. Naunyn-Schmiedeberg's Arch. Pharmacol. 279, 285–300 (1973)
Hoefke, W., Kobinger, W.: Pharmakologische Wirkungen des 2-(2,6-Dichlorphenylamino)-2-imidazolin-hydrochlorids, einer neuen antihypertensiven Substanz. Arzneimittel-Forsch. 16, 1038–1058 (1966)
Hoefke, W., Streller, I.: Central blood pressure lowering capacity of α-adrenolytic agents. Naunyn-Schmiedeberg's Arch. Pharmacol. 294, R21 (1976)
Keller, H. H., Bartholini, G., Pletscher, A.: Drug-induced changes of striatal cholinergic and dopaminergic functions in rats with spreading depression. J. Pharm. Pharmacol. 25, 433–436 (1973)
Kobinger, W.: Central cardiovascular actions of clonidine. In: Central action of drugs in blood pressure regulation (D. S.Davies and J. L. Reid, eds.), pp. 181–193. Tunbridge Wells: Pitman Medical 1975
König, J. F. R., Klippel, R. A.: The rat brain. A stereotaxic atlas of the forebrain and lower parts of the brain stem. Baltimore: Williams and Wilkins 1963
Maj, J., Sowińska, H., Baran, L., Kapturkiewicz, Z.: The effect of clonidine on locomotor activity in mice. Life Sci. 11, (1), 483–491, (1972)
Modigh, K.: Central and peripheral effects of 5-hydroxytryptophan on motor activity in mice. Psychopharmacologia (Berl.) 23, 48–54 (1972)
Moulds, R. F. W., Jauernig, R. A.: Mechanisms of prazosin collapse. Lancet 1977, I, 200–201
Schmitt, H., Schmitt, H., Fénard, S.: Evidence for an α-sympathomimetic compaonent in the effects of catapresan on vasomotor centres: antagonism by piperoxane. Eur. J. Pharmacol. 14, 98–100 (1971)
Schmitt, H., Schmitt, H., Fénard, S.: New evidence for an α-adrenergic component in the sympathetic centres: centrally mediated decrease in sympathetic tone by L-dopa and its antagonism by piperoxane and yohimbine. Eur. J. Pharmacol. 17, 293–296 (1972)
Siegel, S.: Non-parametric statistics for the behavioral sciences. New York: McGraw-Hill 1956
Spector, S., Sjoerdsma, A., Udenfriend, S.: Blockade of endogenous norepinephrine synthesis by α-methyltyrosine, an inhibitor of tyrosine hydroxylase. J. Pharmacol. Exp. Ther. 147, 86–95 (1965)
Starke, K., Montel, H., Gayk, W., Merker, R.: Comparison of the effects of clonidine on pre- and postsynaptic adrenoceptors in the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch. Pharmacol. 285, 133–150 (1974)
Trolin, G. G.: Involvement of α-adrenergic receptors at different levels of the central nervous system in the regulation of blood pressure and heart frequency. Acta Physiol. Scand., Suppl. 430, 1–41 (1975)
van Zwieten, P. A.: Antihypertensive drugs with a central action. Progr. Pharmacol. 1, 1–63 (1975a)
van Zwieten, P. A.: A benzodioxanhydroxyethylpiperidine derivative with an acute central hypotensive action, different from that of clonidine. A comparison with neuroleptic drugs. Arch. Int. Pharmacodyn. 215, 104–118 (1975b)
Wellens, D., De Wilde, A., van Bogaert, A., van Bogaert, P. P., Wouters, L., Reneman, R. S., Janssen, P. A. J.: Unusual mechanism of hypotensive activity exerted by erythro-1-{1-[2-(1,4-benzodioxan-2-yl)-2-OH-ET]-4-piperidyl}-2-benzimidazolinone (R 28935). Arch. Int. Pharmacodyn. 215, 91–103 (1975a)
Wellens, D., Snoeckx, L., De Reese, R., Kruger, R., van de Water, A., Wouters, L., Reneman, R. S.: Antihypertensive activity of erythro-1-{1-[2-(1,4-benzodioxan-2-yl)-2-OH-ET]-4-piperidyl}-2-benzimidazolinone (R 28935). Arch. Int. Pharmacodyn. 215, 119–132 (1975b)
Wood, A. J., Phelan, E. L., Simpson, F. O.: Cardiovascular effects of prazosin in normotensive and genetically hypertensive rats. Clin. Exp. Pharmacol. Physiol. 2, 297–304 (1975)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Andén, NE., Gomes, C., Persson, B. et al. R 28935 and prazosin: Effects on central and peripheral alpha-adrenoreceptor activity and on blood pressure. Naunyn-Schmiedeberg's Arch. Pharmacol. 302, 299–306 (1978). https://doi.org/10.1007/BF00508299
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00508299